| Literature DB >> 35391523 |
Abstract
Epidemiological studies typically examine the causal effect of exposure on a health outcome. Standardization is one of the most straightforward methods for estimating causal estimands. However, compared to inverse probability weighting, there is a lack of user-centric explanations for implementing standardization to estimate causal estimands. This paper explains the standardization method using basic R functions only and how it is linked to the R package stdReg, which can be used to implement the same procedure. We provide a step-by-step tutorial for estimating causal risk differences, causal risk ratios, and causal odds ratios based on standardization. We also discuss how to carry out subgroup analysis in detail.Entities:
Keywords: Causality; Confounding factors; Epidemiology; Observational study; Standardization
Mesh:
Year: 2022 PMID: 35391523 PMCID: PMC8995931 DOI: 10.3961/jpmph.21.569
Source DB: PubMed Journal: J Prev Med Public Health ISSN: 1975-8375
Measures of causation and association
| Name | Measures of causation | Measures of association |
|---|---|---|
| Risk difference | Pr[ | Pr[ |
| Risk ratio |
|
|
| Odds ratio |
|
|
Standardization method for the causal estimand of treatment
| Name | Causal estimand | Standardization method |
|---|---|---|
| Risk difference | Pr[ | ∑c Pr[ |
| Risk ratio |
|
|
| Odds ratio |
|
|
Standardization for the causal effect in subgroups
| Name | Causal estimand for subgroups | Standardization for subgroups |
|---|---|---|
| Risk difference | Pr[ | ∑c Pr[ |
| Risk ratio |
|
|
| Odds ratio |
|
|
Figure 1Directed acyclic graph for presenting the relationship between variables. AFP, alpha-fetoprotein; MELD, Model for End-Stage Liver Disease; CPC, Child-Pugh classification; BCLC, Barcelona Clinic Liver Cancer.
Comparison of standardization results
| Estimand | Standardization function | stdGlm function |
|---|---|---|
| Risk difference | 0.02 (−0.01, 0.05) | 0.02 (−0.01, 0.05) |
| Relative risk | 1.11 (0.94, 1.27) | 1.11 (0.95, 1.27) |
| Odds ratio | 1.13 (0.93, 1.34) | 1.13 (0.93, 1.33) |
Values are presented as estimate (95% confidence interval).
Results of sensitivity analyses based on different models
| Estimand | Model 1 | Model 2 | Model 3 |
|---|---|---|---|
| Risk difference | 0.02 (−0.01, 0.04) | 0.02 (−0.01, 0.04) | 0.02 (−0.01, 0.04) |
| Relative risk | 1.09 (0.94, 1.25) | 1.10 (0.94, 1.25) | 1.10 (0.94, 1.25) |
| Odds ratio | 1.12 (0.92, 1.32) | 1.12 (0.92, 1.32) | 1.12 (0.92, 1.32) |
Values are presented as estimate (95% confidence interval).
BCLC, Barcelona Clinic Liver Cancer.
Interaction term between treatment, BCLC stage, and alpha-fetoprotein level and other confounders are included in the model.
Interaction term between treatment, BCLC stage, and cause of liver cancer and other confounders are included in the model.
Interaction term between treatment and Child-Pugh classification and other confounders are included in the model.